Zimeldine induced neuropathies
- PMID: 6327502
- DOI: 10.1177/096032718400300207
Zimeldine induced neuropathies
Abstract
Zimeldine is recently-introduced antidepressant drug. It has a novel pyridylallylamine structure and acts by selective inhibition of 5-hydroxytryptamine re-uptake at central nerve synapses. This communication reports 2 patients who developed neuropathies within 1 week of starting treatment with this drug. This has hitherto not been described.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical